Healthy Directions, LLC, today announced the launch of MeraLean™ Advantage, a unique weight loss supplement formulated by Dr. David Williams that safely and naturally helps people lose weight and also supports normal blood sugar ...
Tags: Healthy Directions, MeraLean™Advantage, weight loss supplement
Vivus has revealed the initial availability of Qsymia (phentermine and topiramate extended-release) capsules CIV in 8,000 Walgreens, Costco and Duane Reade retail pharmacies in the US. Qsymia is indicated as an adjunct to a ...
Tags: Qsymia, Pharmacies, Vivus
Eisai has announced the availability of Belviq (lorcaserin HCl) CIV tablets in the US, which is designed for chronic weight management in adults who are overweight with a comorbidity or obesity. Indicated for people with body mass ...
Tags: Eisai, Weight Management Therapy
Eisai's subsidiary Eisai Laboratorios has submitted a marketing authorization application (MAA) for Belviq (lorcaserin HCl) with the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico. Arena Pharmaceuticals's ...
Tags: Eisai, Mexican Marketing, Belviq
Vivus has received approval from the US Food and Drug Administration (FDA) for its Qsymia as an adjunct to a reduced-calorie diet. Qsymia will be used to manage chronic weight in adult patients with an initial body mass index (BMI) of 30 ...
Arena Pharmaceuticals and Eisai have announced FDA approval of Belviq (lorcaserin HCl) for chronic weight management in adults who are overweight with comorbidity or obese. The FDA approved Belviq as an adjunct to a reduced-calorie diet ...
Tags: Belviq, lorcaserin HCl, chronic weight management, Arena Pharmaceuticals